Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Rebound acid hypersecretion: Which Medications Cause It? (3,025 Reports Across 10 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Rebound acid hypersecretion has been reported as an adverse event with 10 different drugs in the FDA's FAERS database, with 3,025 total reports. 445 of these reports resulted in death.The drugs most commonly associated with Rebound acid hypersecretion are ESOMEPRAZOLE, OMEPRAZOLE, and LANSOPRAZOLE.

3,025
Total Reports
10
Drugs Involved
445
Deaths
352
Hospitalizations
57.6 yrs
Average Patient Age
58.2% / 41.8%
Female / Male

Which Drugs Cause Rebound acid hypersecretion Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
ESOMEPRAZOLE 2,501 3.3% 373 291 3
OMEPRAZOLE 2,350 2.7% 350 291 16
LANSOPRAZOLE 1,713 2.8% 231 187 2
PANTOPRAZOLE 1,581 2.0% 226 195 15
DEXLANSOPRAZOLE 1,160 4.8% 139 108 0
OMEPRAZOLE\SODIUM BICARBONATE 95 4.9% 12 14 0
RABEPRAZOLE 64 0.6% 10 11 0
RANITIDINE 29 0.0% 1 3 0
FAMOTIDINE 12 0.1% 0 2 0
ESOMEPRAZOLE\NAPROXEN 9 0.2% 4 0 0

View all 10 drugs →

Top 3 Drugs Associated With Rebound acid hypersecretion

2,501 reports
2,350 reports
1,713 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)